Financials
- Market Capitalization 968.53 M
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2484 | ANRO Alto Neuroscience, Inc. Common Stock | 28.03 USD | +5.93% | +5.34% | +30.25% | +930.51% | 983.68 M USD | ||
| 2486 | VOR Vor Biopharma Inc. - Common Stock | 18.03 USD | -5.80% | -10.74% | +22.24% | +37.63% | 976.97 M USD | ||
| 2497 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.75 USD | +0.22% | -4.71% | +4.56% | +31.96% | 964.81 M USD | ||
| 2498 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.17 USD | -2.25% | -6.47% | +11.28% | +82.35% | 963.91 M USD |
Frequently asked questions about Kura Oncology, Inc. - Common Stock
What is the Kura Oncology, Inc. - Common Stock stock price today?
The current price of Kura Oncology, Inc. - Common Stock (KURA) is 10.91. Over the past 24 hours, the stock has changed by -4.72%. Follow the KURA chart for real-time price dynamics.
What is the stock ticker of Kura Oncology, Inc. - Common Stock?
Kura Oncology, Inc. - Common Stock trades under the ticker KURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kura Oncology, Inc. - Common Stock stock going up?
KURA has changed by -2.76% over the last week, +18.85% over the last month, and +70.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kura Oncology, Inc. - Common Stock net income for the last quarter?
Kura Oncology, Inc. - Common Stock reported net income of -73.33 M for the last quarter. The previous quarter showed -81 M, which means net income changed by +9.46%.
How many employees does Kura Oncology, Inc. - Common Stock have?
As of the latest available data, Kura Oncology, Inc. - Common Stock has 260 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kura Oncology, Inc. - Common Stock EBITDA?
Kura Oncology, Inc. - Common Stock EBITDA is -79.25 M, and its EBITDA margin is -433.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kura Oncology, Inc. - Common Stock stock?
You can buy Kura Oncology, Inc. - Common Stock (KURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kura Oncology, Inc. - Common Stock stock?
Investing in Kura Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KURA chart and related analysis on metatrader.com as part of your research.